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In-Human DemonstrationContrast Echocardiography (CE) using microbubble
contrast agents enables sensitive imaging of chamber
ﬂow dynamics andmyocardial perfusion (1). However,
the clinical value of CE is affected by the image
quality achievable by the existing systems. Recent
advances in ultrasound engineering, by transmitting
nonfocused waves and digital beamforming, have
made it possible to achieve thousands of frames per
second (2) and offered new opportunities for imaging
the dynamics of the heart. Although high frame-rate
(HFR) echocardiography has recently been shown,
challenges exist in noncontrast applications due to the
difﬁculty of generating sufﬁcient tissue harmonic
signals in deep tissue using nonfocused waves,
reducing image quality (3). In CE, such challenges
disappear because the nonfocused waves can generate
signiﬁcant harmonics from microbubbles. HFR acqui-
sition has the potential to enhance the imaging of
both intraventricular ﬂow and myocardial perfusion,
although the mechanism of impacts is different. For
imaging ﬂow, HFR enables tracking of fast ﬂow/vortex
in the chamber. During perfusion imaging, in either
triggered or continuous mode, HFR can acquire up to
w100 frames within the same time as that required by
the existing technique to acquire just a single frame.
This can potentially reduce noise and minimize
heart movement artifacts through temporal ﬁltering
or averaging a signiﬁcant number of frames acquired
within milliseconds. In this work we present, as far
as we are aware, the ﬁrst in human demonstration
of HFR-CE.
Contrast speciﬁc images at 5,500 frames per second
were acquired on healthy human volunteers with
infusion of Sonovue (Bracco Imaging SpA, Milan,
Italy, 1.2 ml/min) (approved by the Imperial College
Research Ethics Committee). Low mechanical index
(0.08 to 0.12) diverging waves and pulse inversion
sequences were transmitted using an ultrasound
research platform (Verasonics, Kirkland, Washington)
and a phased array probe (ATL P4-1, Phillips, Seattle,
Washington). To improve the spatial resolution
and the signal-to-noise ratio, the diverging waves
were steered with 11 steering angles ranging between
15 and 15, and the corresponding echoes werecoherently compounded. A destruction–reperfusion
sequence was implemented to observe myocardium
perfusion replenishment. In addition, conventional
line-by-line scanning was also implemented on the
same system for comparison.
To evaluate the image quality and contrast-to-noise
ratio, a measure of the image contrast between the
chamber and myocardium relative to noise was
calculated on the compounded images and the results
were averaged. Image speckle size at the top, middle,
and bottom part of the images was also calculated and
averaged as a measure of spatial resolution. To quan-
tify the chamber ﬂow dynamics, ultrasound imaging
velocimetry (UIV) (also known as echo-particle image
velocimetry) processing (4) was used to track the
microbubbles and generate a time-resolved ﬂow
velocity map. Finally, the myocardium was
segmented and the time-intensity curves (TICs) of the
myocardium contrast enhancement were calculated.
Results are shown in Figure 1.
For image quality, HFR-CE improves image
contrast-to-noise ratio by an average of 151% over
conventional CE after motion compensation. The
speckle size in the image is also improved by an
average of 30% for the same mechanical index.
Furthermore, the ﬂow velocity map within the cardiac
chambers based on HFR-CE and UIV are successfully
obtained while the tracking failed in the conventional
CE control study (Figure 1). Finally, we are able to
quantify the replenishment of contrast signal after
destruction and generate the TIC as displayed in
Figure 1. Some individual microbubble events are also
observed in the myocardium.
In conclusion, we have shown the feasibility of
HFR-CE in humans. Initial results show signiﬁcant
improvement in image quality, and quantiﬁcation
of both chamber ﬂow and myocardium perfusion is
demonstrated. These are new, experimental tech-
niques demonstrated on a research ultrasound
platform and optimization of the imaging parameters
and data processing algorithms is required for them
to be used for clinical application.Matthieu E.G. Toulemonde, PhD
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FIGURE 1 Human High Frame Rate Contrast Echocardiography
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(Top) Conventional CE (left) versus HFR-CE (middle) frames, and the TIC (right) over the ROI (yellow dashed line) of a human heart. Time 0 corresponds to the bubble
destruction/ﬂash pulse. (Bottom) Chamber ﬂow dynamics visualized by HFR-CE and UIV at different cardiac phases before and after R-wave (R 0.12 s, R 0.02 s, and
R þ0.12 s, respectively). CE ¼ contrast echocardiography; HFR ¼ high frame-rate; ROI ¼ region of interest; TIC ¼ time intensity curve; UIV ¼ ultrasound imaging
velocimetry.
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